GSRX Industries Inc. (GSRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 2.27 Million USD | 272.98% |
| 2018 | -1.31 Million USD | -35909.47% |
| 2017 | -3645.00 USD | -100.73% |
| 2016 | 496.61 Thousand USD | 14.33% |
| 2015 | 434.36 Thousand USD | 14.94% |
| 2014 | 377.9 Thousand USD | 18.61% |
| 2013 | 318.61 Thousand USD | 21.63% |
| 2012 | 261.95 Thousand USD | 30.49% |
| 2011 | 200.74 Thousand USD | 36.76% |
| 2010 | 146.78 Thousand USD | 62.28% |
| 2009 | 90.45 Thousand USD | 162.05% |
| 2008 | 34.51 Thousand USD | 150173.91% |
| 2007 | -23.00 USD | -108.58% |
| 2006 | 268.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 Q2 | 1.47 Million USD | -25.48% |
| 2020 FY | - USD | -100.0% |
| 2020 Q3 | 2.86 Million USD | 94.06% |
| 2020 Q1 | 1.98 Million USD | -12.67% |
| 2019 FY | 2.27 Million USD | 272.98% |
| 2019 Q2 | 2 Million USD | -61.7% |
| 2019 Q1 | 5.23 Million USD | 498.79% |
| 2019 Q3 | 2.13 Million USD | 6.53% |
| 2019 Q4 | 2.27 Million USD | 6.31% |
| 2018 Q4 | -1.31 Million USD | -218.09% |
| 2018 FY | -1.31 Million USD | -35909.47% |
| 2018 Q2 | -779.68 Thousand USD | 12.56% |
| 2018 Q3 | -412.63 Thousand USD | 47.08% |
| 2018 Q1 | -891.68 Thousand USD | -24363.16% |
| 2017 Q2 | -914.52 Thousand USD | -279.09% |
| 2017 Q4 | -3645.00 USD | 92.32% |
| 2017 FY | -3645.00 USD | -100.73% |
| 2017 Q1 | 510.65 Thousand USD | 2.83% |
| 2017 Q3 | -47.43 Thousand USD | 94.81% |
| 2016 Q4 | 496.61 Thousand USD | 3.32% |
| 2016 Q2 | 463.67 Thousand USD | 2.43% |
| 2016 FY | 496.61 Thousand USD | 14.33% |
| 2016 Q1 | 452.67 Thousand USD | 4.21% |
| 2016 Q3 | 480.63 Thousand USD | 3.66% |
| 2015 Q4 | 434.36 Thousand USD | 4.27% |
| 2015 FY | 434.36 Thousand USD | 14.94% |
| 2015 Q3 | 416.58 Thousand USD | 3.29% |
| 2015 Q2 | 403.31 Thousand USD | 2.81% |
| 2015 Q1 | 392.29 Thousand USD | 3.81% |
| 2014 Q2 | 345.41 Thousand USD | 3.29% |
| 2014 Q1 | 334.41 Thousand USD | 4.96% |
| 2014 FY | 377.9 Thousand USD | 18.61% |
| 2014 Q4 | 377.9 Thousand USD | 3.92% |
| 2014 Q3 | 363.65 Thousand USD | 5.28% |
| 2013 Q1 | 273.9 Thousand USD | 4.56% |
| 2013 Q2 | 291.03 Thousand USD | 6.25% |
| 2013 Q4 | 318.61 Thousand USD | 4.54% |
| 2013 FY | 318.61 Thousand USD | 21.63% |
| 2013 Q3 | 304.78 Thousand USD | 4.73% |
| 2012 Q2 | - USD | -100.0% |
| 2012 FY | 261.95 Thousand USD | 30.49% |
| 2012 Q4 | 261.95 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | 213.94 Thousand USD | 6.58% |
| 2011 Q1 | 165.33 Thousand USD | 12.64% |
| 2011 Q4 | 200.74 Thousand USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 FY | 200.74 Thousand USD | 36.76% |
| 2010 Q1 | 109.08 Thousand USD | 20.61% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 146.78 Thousand USD | 62.28% |
| 2010 Q4 | 146.78 Thousand USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | 90.45 Thousand USD | 162.05% |
| 2009 Q4 | 90.45 Thousand USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 FY | 34.51 Thousand USD | 150173.91% |
| 2008 Q3 | 19.61 Thousand USD | 141.78% |
| 2008 Q4 | 34.51 Thousand USD | 76.01% |
| 2008 Q2 | 8111.00 USD | 62292.31% |
| 2008 Q1 | 13.00 USD | 156.52% |
| 2007 FY | -23.00 USD | -108.58% |
| 2007 Q3 | -2757.00 USD | -142.09% |
| 2007 Q4 | -23.00 USD | 99.17% |
| 2007 Q1 | 5872.00 USD | 0.0% |
| 2007 Q2 | 6551.00 USD | 11.56% |
| 2006 FY | 268.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioQuest Corp. | 177.38 Thousand USD | 100.0% |
| High Sierra Technologies, Inc. | 469.78 Thousand USD | 100.0% |
| Instadose Pharma Corp. | - USD | NaN% |